KalVista Pharmaceuticals Ownership | Who Owns KalVista Pharmaceuticals?
KalVista Pharmaceuticals Ownership Summary
KalVista Pharmaceuticals is owned by 109.59% institutional investors, 1.65% insiders. Vr adviser is the largest institutional shareholder, holding 13.55% of KALV shares. American Funds SMALLCAP World A is the top mutual fund, with 6.36% of its assets in KalVista Pharmaceuticals shares.
KALV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | KalVista Pharmaceuticals | 109.59% | 1.65% | -11.24% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vr adviser | 6.73M | 13.55% | $76.07M |
| Suvretta capital management | 4.96M | 9.98% | $56.02M |
| Tang capital management | 4.94M | 9.95% | $55.87M |
| Frazier life sciences management | 4.89M | 9.84% | $55.26M |
| Vestal point capital, lp | 4.67M | 9.42% | $52.85M |
| Blackrock | 2.95M | 6.76% | $34.69M |
| Capital world investors | 3.18M | 6.40% | $35.92M |
| Blackrock funding, inc. /de | 3.13M | 6.30% | $35.38M |
| Vanguard group | 2.26M | 4.83% | $19.10M |
| Silverarc capital management | 1.83M | 3.69% | $20.71M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Allostery investments lp | 40.00K | 5.76% | $452.20K |
| Vr adviser | 6.73M | 5.70% | $76.07M |
| Silverarc capital management | 1.83M | 3.82% | $20.71M |
| Tang capital management | 4.94M | 2.82% | $55.87M |
| Vestal point capital, lp | 4.67M | 2.78% | $52.85M |
| Great point partners | 323.17K | 2.38% | $3.65M |
| Frazier life sciences management | 4.89M | 2.21% | $55.26M |
| Octagon capital advisors lp | 1.37M | 1.91% | $11.60M |
| Dafna capital management | 581.76K | 1.82% | $6.58M |
| Suvretta capital management | 4.96M | 1.69% | $56.02M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | 1.37M | 1.91% | 1.37M |
| Woodline partners lp | 1.29M | 0.07% | 680.15K |
| Blackrock | 2.95M | 0.00% | 512.88K |
| Ubs group | 374.63K | 0.00% | 331.20K |
| Ikarian capital | 198.53K | 0.43% | 198.53K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | - | - | -1.16M |
| Bioimpact capital | - | - | -896.91K |
| Great point partners | 323.17K | 2.38% | -691.20K |
| Driehaus capital management | - | - | -535.72K |
| Perceptive advisors | - | - | -500.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Octagon capital advisors lp | 1.37M | 1.91% | 1.37M | $11.60M |
| Ikarian capital | 198.53K | 0.43% | 198.53K | $2.24M |
| Nan fung trinity (hk) | 154.52K | 0.21% | 154.52K | $1.75M |
| Boothbay fund management | 148.93K | 0.03% | 148.93K | $1.68M |
| Norges bank | 131.30K | 0.00% | 131.30K | $1.55M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Fortitude family office | -3.00 |
| Ifp advisors | -4.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Creekmur asset management | -23.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 145 | 5.07% | 54,415,240 | -0.92% | 109 | 1.01% | 80 | 12.68% | 35 | -7.89% |
| Mar 31, 2025 | 138 | 5.34% | 54,920,723 | -0.49% | 104 | 0.75% | 71 | -7.79% | 38 | 26.67% |
| Dec 31, 2024 | 126 | 0.80% | 48,891,669 | 0.99% | 104 | 0.95% | 71 | 4.41% | 31 | 3.33% |
| Sep 30, 2024 | 125 | 2.46% | 48,412,312 | 0.37% | 104 | 0.86% | 68 | 7.94% | 30 | -9.09% |
| Jun 30, 2024 | 122 | -7.58% | 48,235,227 | 2.65% | 110 | 0.95% | 63 | -20.25% | 33 | -8.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 3.18M | 6.36% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.37M | 2.74% | -30.35K |
| Vanguard US Total Market Shares ETF | 1.20M | 2.41% | - |
| iShares Russell 2000 ETF | 899.86K | 1.80% | -17.11K |
| International Biotechnology Ord | 574.53K | 1.15% | 19.58K |
| SPDR® S&P Biotech ETF | 568.36K | 1.14% | 14.03K |
| Vanguard Institutional Extnd Mkt Idx Tr | 408.90K | 0.82% | -176.97K |
| MEDICAL BioHealth EUR Acc | 385.67K | 0.77% | 123.22K |
| Fidelity Small Cap Index | 378.62K | 0.76% | -15.51K |
| Emerald Growth A | 357.34K | 0.72% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 08, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | $115.54K |
| Aug 25, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | $19.86K |
| Aug 25, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | $26.22K |
| Aug 25, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | $31.35K |
| Aug 22, 2025 | Sweeny Nicole | Chief Commercial Officer | Sell | $24.65K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 13 |
| 2025 Q2 | 1 | 9 |
| 2025 Q1 | 8 | 6 |
| 2024 Q4 | - | 6 |
| 2024 Q3 | - | 6 |
KALV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools